Literature DB >> 10369487

Nitric oxide-dependent relaxation induced by M1 muscarinic receptor activation in the rat small intestine.

C Olgart1, H H Iversen.   

Abstract

The aim of the present study was to investigate whether muscarinic M1 receptor activation induces intestinal relaxation via nerve-dependent nitric oxide formation. Mechanical activity in longitudinal segments of rat jejunum was recorded isotonically in organ baths. The muscarinic M1 receptor agonist 4-[[[(3-Chlorophenyl)amino]carbonyl]oxy]-N,N,N,-trimethyl-2-butyn- 1-ammonium chloride (McN-A-343, 10(-7)-10(-4) M) induced a concentration-dependent relaxation of rat jejunum. Relaxations induced by McN-A-343 (10(-5) M) were inhibited by the M1 receptor antagonist telenzepine (10(-8) M), and enhanced by the M3 receptor antagonist para-fluorohexahydrosiladifenidol (p-F-HHSiD; 3x10(-7) M). The inhibitory responses induced by McN-A-343 were abolished by the nitric oxide synthase inhibitors Nomega-nitro-L-arginine (L-NOARG; 10(-4) M) and Nomega-monomethyl-L-arginine (L-NMMA; 3x10(-5) M), the guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one (ODQ; 10(-5) M), and by tetrodotoxin (TTX; 3x10(-7) M). Guanethidine or hexamethonium did not affect inhibitory responses induced by McN-A-343. In conclusion, McN-A-343 induces nerve-dependent, nitrergic relaxations in rat jejunum, via activation of muscarinic M1 receptors. Hence, selective muscarinic M1 receptor agonists or antagonists might offer possibilities for pharmacological manipulation of the NO system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369487      PMCID: PMC1566002          DOI: 10.1038/sj.bjp.0702529

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Nerve stimulation-induced nitric oxide release as a consequence of muscarinic M1 receptor activation.

Authors:  H H Iversen; N P Wiklund; C Olgart; L E Gustafsson
Journal:  Eur J Pharmacol       Date:  1997-07-23       Impact factor: 4.432

2.  Effects of nicotine on gastric antral and duodenal contractile activity in the dog.

Authors:  G M Carlson; R W Ruddon; C C Hug; P Bass
Journal:  J Pharmacol Exp Ther       Date:  1970-04       Impact factor: 4.030

3.  The binding of [3H]telenzepine to muscarinic acetylcholine receptors in calf forebrain.

Authors:  C Schudt; C Auriga; B Kinder; N J Birdsall
Journal:  Eur J Pharmacol       Date:  1988-01-05       Impact factor: 4.432

4.  The effects of L-arginine and NG-monomethyl L-arginine on the response of the rat anococcygeus muscle to NANC nerve stimulation.

Authors:  J S Gillespie; X R Liu; W Martin
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

5.  Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes.

Authors:  G Lambrecht; R Feifel; M Wagner-Röder; C Strohmann; H Zilch; R Tacke; M Waelbroeck; J Christophe; H Boddeke; E Mutschler
Journal:  Eur J Pharmacol       Date:  1989-09-01       Impact factor: 4.432

6.  Modification by L-NG-monomethyl arginine (L-NMMA) of the response to nerve stimulation in isolated dog mesenteric and cerebral arteries.

Authors:  N Toda; T Okamura
Journal:  Jpn J Pharmacol       Date:  1990-01

7.  Muscarinic M1 receptors stimulate a nonadrenergic noncholinergic inhibitory pathway in the isolated rat duodenum.

Authors:  R Micheletti; A Schiavone; A Giachetti
Journal:  J Pharmacol Exp Ther       Date:  1988-02       Impact factor: 4.030

8.  Pharmacological characterization of muscarinic receptors involved in McN-A-343-induced effects on intestinal motility and heart rate in conscious dogs.

Authors:  A Schiavone; A Sagrada; R Micheletti; A Giachetti
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

9.  Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinic drug.

Authors:  M Eltze; S Gönne; R Riedel; B Schlotke; C Schudt; W A Simon
Journal:  Eur J Pharmacol       Date:  1985-06-07       Impact factor: 4.432

10.  Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter.

Authors:  H Bult; G E Boeckxstaens; P A Pelckmans; F H Jordaens; Y M Van Maercke; A G Herman
Journal:  Nature       Date:  1990-05-24       Impact factor: 49.962

View more
  6 in total

1.  Regional differences in neostigmine-induced contraction and relaxation of stomach from diabetic guinea pig.

Authors:  Joseph Cellini; Karyn DiNovo; Jessica Harlow; Kathy J LePard
Journal:  Auton Neurosci       Date:  2010-11-13       Impact factor: 3.145

2.  M(2) and M(3) muscarinic receptor-mediated contractions in longitudinal smooth muscle of the ileum studied with receptor knockout mice.

Authors:  Toshihiro Unno; Hayato Matsuyama; Takashi Sakamoto; Mai Uchiyama; Yusuke Izumi; Hiroyuki Okamoto; Masahisa Yamada; Jürgen Wess; Seiichi Komori
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

3.  Neostigmine-induced contraction and nitric oxide-induced relaxation of isolated ileum from STZ diabetic guinea pigs.

Authors:  Joseph Cellini; Anne Marie Zaura Jukic; Kathy J LePard
Journal:  Auton Neurosci       Date:  2011-08-30       Impact factor: 3.145

4.  Roles of PACAP and PHI as inhibitory neurotransmitters in the circular muscle of mouse antrum.

Authors:  Makiko Toyoshima; Tadayoshi Takeuchi; Hiroto Goto; Kazunori Mukai; Norihito Shintani; Hitoshi Hashimoto; Akemichi Baba; Fumiaki Hata
Journal:  Pflugers Arch       Date:  2005-11-15       Impact factor: 3.657

5.  Activation of 5-HT3 receptors in the rat and mouse intestinal tract: a comparative study.

Authors:  Navinisha Chetty; Helen R Irving; Ian M Coupar
Journal:  Br J Pharmacol       Date:  2006-06-12       Impact factor: 8.739

6.  Functional muscarinic cholinoceptors in the isolated canine ureter.

Authors:  Yoshitaka Tomiyama; Isao Wanajo; Yoshinobu Yamazaki; Makoto Murakami; Masami Kojima; Nobuo Shibata
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-03-07       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.